Lung And Spleen, And Functions Of Phlegm Method To Treat Pediatric Asthma Remission Of Lung Spleen Virtual Wind Sputum Intrinsic Syndrome Clinical Studies

BACKGROUND: During the past 30 years, the prevalence of asthma in childrenhas increased 15 times, by an average of 1% per year. Families and societysuffer great burdens for the hospitalizations of childhood asthma patients;hence childhood asthma becomes a major issue for the health-care department.THEORY: Stating different views on the etiology and pathology of asthma baseon the TCM history. The cause of asthma are attributed to deficiency of lung,spleen and kidney, deficiency of qi yin yah, stag nation of qi and stasisof blood, accumulation of wind-phlegm in lung, and usually triggered byinvasion of pathogenic factors. Pathology of asthma is deficiency in originand excess in superficiality; therefore clinically regression and remissionbecome an issue. Proper treatments are based on the results from carefuldifferentiations of patients’ syndromes. During the remission stage, it isimportant to prevent contact with any sensitinogen and improve patients’immunity by TCM methods. This paper studies one type of asthma: "deficiencyof lung and spleen qi and accumulation of wind-phlegm", the most common typeto be seen in the southern Taiwan. The prescription used is Junyu Ke Li. Itis a combination of Yupingfeng San (Replenishing qi, consolidating thesuperficies and arresting perspiration), Xianshaliujunzi Tang (Reinforcingand fortifying the spleen), Xinyi and Wuweizi. This prescription was usedon asthmatic children in theirremission stage in hope of finding an effectiveand safe method of treating this disease.METHOD: Eighty asthmatic children in remission stage of "deficiency of lung and spleen qi and accumulation of wind-phlegm" syndrome, picked byrandom-sampling, were classified into two groups (group A and B). Group Ais the experimental group which consists 40 patients (take no anti-allergydrugs). Group B is the control group which also consists 40 patients (takeanti-allergy drugs regularly). Patients in group a take no anti-allergy drugsbut Junyu Ke Li for 3 months. Patients in group b take only inhaled steroidsfor the same period of time.RESULT: Effective rate for group a is 90％and 67.5％for group b. Statisticalanalysis shows great difference between the two groups. Group a has a farbetter improvement in cardinal symptom and secondary symptom than group b.This result shows that Junyu Ke Li performs significantly better than inhaledsteroids in treating asthmatic children in remission stage. Junyu Ke Li canstrengthen lung and consolidate the superficies, reinforce and fortify thespleen, dispel cold and eliminate phlegm. Overall it benefits the patients’immune system and lowers the rate of catching common cold; hence decreasesthe occurrence of asthma. This "strengthening origin" method has goodcurative effect on asthmatic patients in remission stage and is worthconsidering for clinical applications.